Literature DB >> 19052836

Diagnosis delay in patients with ankylosing spondylitis: factors and outcomes--an Indian perspective.

Rohit Aggarwal1, Anand N Malaviya.   

Abstract

This study focuses on the causes and consequences of delay in diagnosis of ankylosing spondylitis (AS). Seventy consecutive patients presenting at a rheumatology clinic in India were studied. Mean (+/-S.D) delay in diagnosis was 6.9 (+/-5.2) years. The main cause of delay was incorrect diagnosis as non-specific back pain (19/54, 35.1%), degenerative disc disease (14/54, 25.9%), rheumatoid arthritis (11/54, 20.37%), and tuberculosis of spine (9/54, 16.6%) in that order, for which the patient received prolonged treatment. Absence of extra-articular manifestations and juvenile age also significantly correlated with diagnostic delay. Delay in diagnosis resulted in significantly worse disease activity index (BASDAI), functional index (BASFI), and damage index (BASMI). Most incorrect initial diagnoses were made by orthopedicians (75.9%), followed by general physician (50%), and rheumatologist (12%). Continuing medical education workshops with a focus on clinical diagnosis of inflammatory back pain may help in early diagnosis of AS.

Entities:  

Mesh:

Year:  2008        PMID: 19052836     DOI: 10.1007/s10067-008-1049-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  20 in total

1.  New York clinical criteria for ankylosing spondylitis. A statistical evaluation.

Authors:  J M Moll; V Wright
Journal:  Ann Rheum Dis       Date:  1973-07       Impact factor: 19.103

2.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

3.  Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha.

Authors:  Jennifer D Gorman; Kenneth E Sack; John C Davis
Journal:  N Engl J Med       Date:  2002-05-02       Impact factor: 91.245

4.  Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial.

Authors:  J Braun; J Brandt; J Listing; A Zink; R Alten; W Golder; E Gromnica-Ihle; H Kellner; A Krause; M Schneider; H Sörensen; H Zeidler; W Thriene; J Sieper
Journal:  Lancet       Date:  2002-04-06       Impact factor: 79.321

5.  Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria.

Authors:  Martin Rudwaleit; Anke Metter; Joachim Listing; Joachim Sieper; Jürgen Braun
Journal:  Arthritis Rheum       Date:  2006-02

6.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

7.  Ankylosing spondylitis--an analytical review of 1500 patients: the changing pattern of disease.

Authors:  A Calin; J Elswood; S Rigg; S M Skevington
Journal:  J Rheumatol       Date:  1988-08       Impact factor: 4.666

8.  Diagnosis delay in patients with ankylosing spondylitis: possible reasons and proposals for new diagnostic criteria.

Authors:  Umit Dincer; Engin Cakar; M Zeki Kiralp; Hasan Dursun
Journal:  Clin Rheumatol       Date:  2007-09-26       Impact factor: 2.980

9.  Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis.

Authors:  J Brandt; A Khariouzov; J Listing; H Haibel; H Sörensen; L Grassnickel; M Rudwaleit; J Sieper; J Braun
Journal:  Arthritis Rheum       Date:  2003-06

10.  Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis.

Authors:  M Rudwaleit; J Listing; J Brandt; J Braun; J Sieper
Journal:  Ann Rheum Dis       Date:  2004-03-22       Impact factor: 19.103

View more
  20 in total

Review 1.  Rheumatology in India--quo vadis?

Authors:  Rohini Handa
Journal:  Nat Rev Rheumatol       Date:  2014-11-04       Impact factor: 20.543

2.  Clinical characteristics of peripheral spondyloarthritis without psoriasis, inflammatory enteropathy or preceding infection, from a single rheumatology clinic in northern India.

Authors:  Anand Narayan Malaviya; Neha Agrawal; Nilesh Sahebrao Patil
Journal:  Clin Rheumatol       Date:  2017-06-13       Impact factor: 2.980

3.  Delayed diagnosis is linked to worse outcomes and unfavourable treatment responses in patients with axial spondyloarthritis.

Authors:  Mi Ryoung Seo; Hae Lim Baek; Hyun Hwa Yoon; Hee Jung Ryu; Hyo-Jin Choi; Han Joo Baek; Kwang-Pil Ko
Journal:  Clin Rheumatol       Date:  2014-09-05       Impact factor: 2.980

4.  Relationship between diagnosis delay and disease features in Moroccan patients with ankylosing spondylitis.

Authors:  Yousra Ibn Yacoub; Bouchra Amine; Assia Laatiris; Rachida Bensabbah; Najia Hajjaj-Hassouni
Journal:  Rheumatol Int       Date:  2010-11-26       Impact factor: 2.631

5.  Prevalence of HLA-B27 in the general population and in patients with axial spondyloarthritis in Saudi Arabia.

Authors:  Mohammed A Omair; Fatmah K AlDuraibi; Mohammed K Bedaiwi; Sultana Abdulaziz; Waleed Husain; Maha El Dessougi; Hind Alhumaidan; Hana J Al Khabbaz; Ibrahim Alahmadi; Maha A Omair; Salman Al Saleh; Khalid Alismael; Moheeb Al Awwami
Journal:  Clin Rheumatol       Date:  2017-04-29       Impact factor: 2.980

6.  Clinical characteristics of patients with ankylosing spondylitis in India.

Authors:  Rohit Aggarwal; Anand N Malaviya
Journal:  Clin Rheumatol       Date:  2009-07-18       Impact factor: 2.980

7.  Treatment of rheumatoid arthritis (RA) in India-how and by whom: results from a speciality clinic-use of low-dose methotrexate (MTX) was inexplicably suboptimal.

Authors:  Anand N Malaviya; S B Gogia
Journal:  Clin Rheumatol       Date:  2016-04-28       Impact factor: 2.980

Review 8.  Seronegative arthritis in South Asia: an up-to-date review.

Authors:  Anand N Malaviya; Sujata Sawhney; Narinder K Mehra; Uma Kanga
Journal:  Curr Rheumatol Rep       Date:  2014-04       Impact factor: 4.592

9.  Baseline sacroiliac joint magnetic resonance imaging abnormalities and male sex predict the development of radiographic sacroiliitis.

Authors:  Servet Akar; Sibel Isik; Bilge Birlik; Dilek Solmaz; Ismail Sari; Fatos Onen; Nurullah Akkoc
Journal:  Clin Rheumatol       Date:  2013-06-14       Impact factor: 2.980

10.  Impact of gender, work, and clinical presentation on diagnostic delay in Italian patients with primary ankylosing spondylitis.

Authors:  F Bandinelli; G Salvadorini; A Delle Sedie; L Riente; S Bombardieri; M Matucci-Cerinic
Journal:  Clin Rheumatol       Date:  2015-08-04       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.